Clinical trial IO-001
Phase I/Ib First-in-Human study of EOS100850 in patients with advanced solid tumors - IO-001
| Organ | Multiple |
|---|---|
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | iTeos |
| EudraCT Identifier | 2018-003173-10 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03873883 |
| Inclusion criteria | 4 weeks free from treatment |
| Last update |